MAIA Biotechnology
David E. Gerber, MD, is a Professor of Internal Medicine and Population & Data Sciences at UT Southwestern Medical Center. Within the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, Dr. Gerber serves as Associate Director of Clinical Research. He is an active clinical investigator with more than 180 publications and continuous federal and foundation research funding for more than 10 years. In the area of cancer immunotherapy, Dr. Gerber has a particular interest in the impact of autoimmune comorbidities, the recognition and characterization of immune-related adverse events, and biomarkers for the prediction and diagnosis of these autoimmune toxicities.
This person is not in the org chart
This person is not in any offices
MAIA Biotechnology
2 followers
MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.